Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2026 | 04-2025 | 04-2024 | 04-2023 | 04-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,604 | 15,172 | 50,180 | 68,040 | 85,401 |
| Marketable Securities | 18,479 | 366 | N/A | N/A | N/A |
| Receivables | 241 | 3,696 | N/A | N/A | N/A |
| Other current assets | 0 | 2,917 | 0 | 0 | 0 |
| TOTAL | $37,421 | $22,375 | $50,440 | $68,148 | $85,495 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 1,572 | 1,572 |
| Intangibles | 0 | 1,549 | 1,549 | 3,549 | 3,549 |
| Other Non-Current Assets | 9,333 | 31,244 | 7,915 | 8 | 8 |
| TOTAL | $9,333 | $32,793 | $9,464 | $5,129 | $5,129 |
| Total Assets | $46,753 | $55,168 | $59,904 | $73,277 | $90,624 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 271 | 399 | 389 | 128 | 205 |
| Accrued Expenses | 523 | 2,515 | 735 | 458 | 499 |
| Other current liabilities | 33 | N/A | 6,297 | N/A | N/A |
| TOTAL | $826 | $2,914 | $7,421 | $587 | $704 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 25 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 12,632 | 338 | 24,835 | 0 | 0 |
| TOTAL | $12,632 | $363 | $24,835 | $N/A | $N/A |
| Total Liabilities | $13,458 | $3,277 | $32,256 | $587 | $704 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,736 | 6,796 | 7,709 | 8,778 | 20,749 |
| Common Shares | 3 | 2 | 2 | 2 | 2 |
| Retained earnings | -104,394 | -84,969 | -115,625 | -115,959 | -111,649 |
| Other shareholders' equity | -30 | 368 | -64 | 416 | -16 |
| TOTAL | $33,295 | $51,891 | $27,648 | $72,690 | $89,920 |
| Total Liabilities And Equity | $46,753 | $55,168 | $59,904 | $73,277 | $90,624 |